Publication:
Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.

dc.contributor.authorRodriguez, Carlos F
dc.contributor.authorEscudero-Bravo, Paloma
dc.contributor.authorDíaz, Lucía
dc.contributor.authorBartoccioni, Paola
dc.contributor.authorGarcía-Martín, Carmen
dc.contributor.authorGilabert, Joan G
dc.contributor.authorBoskovic, Jasminka
dc.contributor.authorGuallar, Víctor
dc.contributor.authorErrasti-Murugarren, Ekaitz
dc.contributor.authorLlorca Blanco, Oscar Antonio
dc.contributor.authorPalacín, Manuel
dc.contributor.funderWellcome Trust:es_ES
dc.contributor.funderUK Research and Innovation
dc.contributor.funderFundación La Caixa
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea
dc.date.accessioned2024-09-16T08:16:59Z
dc.date.available2024-09-16T08:16:59Z
dc.date.issued2021-12-07
dc.description.abstractDespite having similar structures, each member of the heteromeric amino acid transporter (HAT) family shows exquisite preference for the exchange of certain amino acids. Substrate specificity determines the physiological function of each HAT and their role in human diseases. However, HAT transport preference for some amino acids over others is not yet fully understood. Using cryo-electron microscopy of apo human LAT2/CD98hc and a multidisciplinary approach, we elucidate key molecular determinants governing neutral amino acid specificity in HATs. A few residues in the substrate-binding pocket determine substrate preference. Here, we describe mutations that interconvert the substrate profiles of LAT2/CD98hc, LAT1/CD98hc, and Asc1/CD98hc. In addition, a region far from the substrate-binding pocket critically influences the conformation of the substrate-binding site and substrate preference. This region accumulates mutations that alter substrate specificity and cause hearing loss and cataracts. Here, we uncover molecular mechanisms governing substrate specificity within the HAT family of neutral amino acid transporters and provide the structural bases for mutations in LAT2/CD98hc that alter substrate specificity and that are associated with several pathologies.es_ES
dc.description.peerreviewedNoes_ES
dc.description.sponsorshipThe datasets of LAT2/4F2hc used in this study were obtained at the UK National eBIC under Block Allocation Group (BAG) proposal EM20135 (Stop cancer-structural studies of macromolecular com-plexes involved in cancer by cryo-EM) , funded by the Wellcome Trust, Medi-cal Research Council (MRC) , and Biotechnology and Biological Sciences Research Council (BBRSC) , and at the Leicester Institute of Structural and Chemical Biology. We acknowledge the help of Diamond Light Source for access to eBIC and the help of Dr. Christos Savva at Leicester. We thank Nick Berrow (Protein Expression Facility at the Institute for Research in Biomedi-cine (IRB) Barcelona) for the construction of the vectors with the tagged ver-sions of hLAT2 and hCD98hc used in this study. We thank Ismael Mingarro for his help with the calculation of ER membrane insertion of hLAT2 and V460E mutant. We also thank Rafael Fernandez Leiro at Centro Nacional deInvestigaciones Oncologicas (CNIO) for discussions about image processing of the data. This work was funded by "la Caixa" Foundation, Health Research Grant 2020 (LCF/PR/HR20/52400017) to M.P. and O.L.; by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI) Grants SAF2015-64869-R-FEDER and RTI2018-094211-B-100-FEDER to M.P. and SAF2017-82632-P to O.L.; cofunded by the European Regional Development Fund (ERDF) ; the sup-port of Catalan Government (Grant 2017 SGR 961) to M.P.; the support of the NIH Carlos III to CNIO; Grants Y2018/BIO4747 and P2018/NMT4443 from the Autonomous Region of Madrid and cofunded by the European Social Fundand the ERDF to O.L. C.F.R. is funded by BES-2015-071348 PhD fellowship by the MCIU/AEI. We gratefully acknowledge institutional funding from the Spanish State Research Agency of the Spanish Ministry of Science and Innova-tion-Programa Estatal de Fomento de la Investigacion Cientifica y Tecnica de Excelencia-Centres of Excellence "Severo Ochoa" CEX2019-000891-S and CEX2019-000913-S. IRB Barcelona is a member of the Centres de Recerca de Catalunya (CERCA) System of the Catalan Government. P.B. is supported by a Centro de Investigaci?on Biome?dica en Red de Enfermedades Raras (CIBERER) contract.es_ES
dc.format.number49es_ES
dc.format.volume118es_ES
dc.identifier.citationProc Natl Acad Sci U S A . 2021;118(49):e2113573118.es_ES
dc.identifier.doi10.1073/pnas.2113573118es_ES
dc.identifier.e-issn1091-6490es_ES
dc.identifier.journalProceedings of the National Academy of Sciences of the United States of Americaes_ES
dc.identifier.pmchttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670485/pdf/pnas.202113573.pdf
dc.identifier.pubmedID34848541es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23089
dc.language.isoenges_ES
dc.publisherNational Academy of Sciences
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF2015-64869-R-FEDERes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTI2018-094211-B-100-FEDERes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF2017-82632-Pes_ES
dc.relation.publisherversionhttps://doi.org/10.1073/pnas.2113573118es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Complejos Macromoleculares en la Respuesta a Daños en el DNAes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAdaptor Proteins, Signal Transducinges_ES
dc.subject.meshAmino Acid Transport Systemses_ES
dc.subject.meshAmino Acid Transport Systems, Neutrales_ES
dc.subject.meshAmino Acidses_ES
dc.subject.meshAmino Acids, Neutrales_ES
dc.subject.meshBiological Transportes_ES
dc.subject.meshCryoelectron Microscopyes_ES
dc.subject.meshFusion Regulatory Protein 1, Heavy Chaines_ES
dc.subject.meshHeLa Cellses_ES
dc.subject.meshHumanses_ES
dc.subject.meshLarge Neutral Amino Acid-Transporter 1es_ES
dc.subject.meshProtein Domainses_ES
dc.subject.meshStructure-Activity Relationshipes_ES
dc.subject.meshSubstrate Specificityes_ES
dc.titleStructural basis for substrate specificity of heteromeric transporters of neutral amino acids.es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionAMes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication400c30f1-1f41-4b0d-8b2e-327d5b9c3e7e
relation.isAuthorOfPublication63cfd8da-7c4d-43c3-a627-57b70f73572a
relation.isAuthorOfPublication.latestForDiscovery400c30f1-1f41-4b0d-8b2e-327d5b9c3e7e
relation.isFunderOfPublication69c5c2cf-27f2-4969-bdc7-1fd0320137eb
relation.isFunderOfPublicationf04d23ec-a91d-4242-88b0-cc436888f8a2
relation.isFunderOfPublication1aef4c3b-1ee5-4534-83b4-3f3811c67280
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationb029ca7c-43c2-46be-af9e-b34b7f455d94
relation.isFunderOfPublication.latestForDiscovery69c5c2cf-27f2-4969-bdc7-1fd0320137eb
relation.isPublisherOfPublicationae2cc6ce-1cb5-456f-8932-8f02f693fccf
relation.isPublisherOfPublication.latestForDiscoveryae2cc6ce-1cb5-456f-8932-8f02f693fccf

Files